Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $46.3 million.

  • Medifast's Non-Current Assets fell 3369.05% to $46.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $236.0 million, marking a year-over-year decrease of 1817.26%. This contributed to the annual value of $46.3 million for FY2025, which is 3369.05% down from last year.
  • Medifast's Non-Current Assets amounted to $46.3 million in Q4 2025, which was down 3369.05% from $60.4 million recorded in Q3 2025.
  • Medifast's Non-Current Assets' 5-year high stood at $97.2 million during Q2 2022, with a 5-year trough of $44.5 million in Q1 2021.
  • In the last 5 years, Medifast's Non-Current Assets had a median value of $76.7 million in 2021 and averaged $76.9 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 11896.1% in 2021, then crashed by 3369.05% in 2025.
  • Over the past 5 years, Medifast's Non-Current Assets (Quarter) stood at $91.5 million in 2021, then rose by 2.15% to $93.4 million in 2022, then dropped by 8.08% to $85.9 million in 2023, then dropped by 18.71% to $69.8 million in 2024, then tumbled by 33.69% to $46.3 million in 2025.
  • Its Non-Current Assets stands at $46.3 million for Q4 2025, versus $60.4 million for Q3 2025 and $62.9 million for Q2 2025.